Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era

被引:9
|
作者
Nayak, Sarat Kumar [1 ]
Das, Bijay Kumar [1 ]
Das, Surya Narayan [1 ]
Mohapatra, Namita [2 ]
Nayak, Suryakanti [1 ]
Bhuyan, Lipsa [3 ]
机构
[1] SCB Dent Coll & Hosp, Dept Oral Pathol & Microbiol, Cuttack 753007, Orissa, India
[2] SCB Dent Coll & Hosp, Dept Med, Cuttack, Orissa, India
[3] Kalinga Inst Dent Sci, Dept Oral & Maxillofacial Pathol, Bhubaneswar, Odisha, India
关键词
Acquired immunodeficiency syndrome; antiretroviral therapy; cluster of differentiation 4; human immunodeficiency virus;
D O I
10.4103/0976-237X.194122
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The human immunodeficiency virus (HIV) infection which manifests as acquired immunodeficiency syndrome (AIDS) is a disease involving the defects of the T-lymphocyte arm of the immune system. Certain laboratory parameters such as the cluster of differentiation (CD4) count and clinical parameters have long been used as markers of disease progression. In industrialized countries, many studies show a highly correlation between the incidence of oral lesions and immunosuppression and hence, can be used as a marker of immunosuppression. This might not be applicable to a developing country like India. In this study, efforts have been made to supplement the present knowledge on various aspects of oral manifestations in HIV patients in the Indian subcontinent. Aims: To correlate the oral manifestations in HIV/AIDS patients to the level of circulating CD4+ T-lymphocyte count and their effect in anti-retroviral therapy (ART). Subjects and Methods: A total of 104 HIV positive patients were examined for oral lesions. The CD4 count estimated on the same day by fluorescent activated cell sort count machine was then correlated with various oral lesions. Results: Oral manifestations appeared when CD4 count decreased below 500 cells/mm(3). Moreover, oral lesions found at different stages showed very strong correlation to their respective CD4 count. Furthermore, there was considerable decline in the incidence of oral manifestations in patients undergoing highly active ART. Conclusions: Oral manifestations are highly predictive markers of severe immune deterioration and disease progression in HIV patients.
引用
收藏
页码:539 / 543
页数:5
相关论文
共 50 条
  • [41] Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy
    Morris, A
    Creasman, J
    Turner, J
    Luce, JM
    Wachter, RM
    Huang, L
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) : 262 - 267
  • [42] Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy
    Giuliani, Michele
    Lajolo, Carlo
    Sartorio, Alessandra
    Lacaita, Maria Grazia
    Capodiferro, Saverio
    Cauda, Roberto
    Rezza, Giovanni
    Tumbarello, Mario
    MEDICAL SCIENCE MONITOR, 2009, 15 (06): : PH49 - PH56
  • [43] Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy
    Bhaskaran, Krishnan
    Mussini, Cristina
    Antinori, Andrea
    Walker, Ann Sarah
    Dorrucci, Maria
    Sabin, Caroline
    Phillips, Andrew
    Porter, Kholoud
    ANNALS OF NEUROLOGY, 2008, 63 (02) : 213 - 221
  • [44] Frequency of Pancreatic Hyperamylasemia in Human Immunodeficiency Virus-Positive Patients in the Highly Active Antiretroviral Therapy Era
    Szoke, Dominika
    Ridolfo, Annalisa
    Valente, Cristina
    Galli, Massimo
    Panteghini, Mauro
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (01) : 128 - 133
  • [45] Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era
    Abbott, KC
    Hypolite, I
    Welch, PG
    Agodoa, LYC
    JOURNAL OF NEPHROLOGY, 2001, 14 (05) : 377 - 383
  • [46] The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda
    Frantz, J. M.
    Murenzi, A.
    SAHARA J-JOURNAL OF SOCIAL ASPECTS OF HIV-AIDS, 2013, 10 (3-4) : 113 - 118
  • [47] Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy
    Jullien, V
    Tréluyer, JM
    Rey, E
    Jaffray, P
    Krivine, A
    Moachon, L
    Lillo-Le Louet, A
    Lescoat, A
    Dupin, N
    Salmon, D
    Pons, G
    Urien, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3361 - 3366
  • [48] Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy
    Dzwonek, A
    Clapson, M
    Withey, S
    Bates, A
    Novelli, V
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (02) : 183 - 184
  • [49] Subclinical functional and structural cardiomyopathy among patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy
    Maria De las Nieves Montoro Lopez, M.
    Soto, C. I.
    Florez Gomez, R.
    Alonso Ladreda, A.
    Ponz De Antonio, I.
    Bernardino, J. I.
    Refoyo Salicio, E.
    Rios Blanco, J. J.
    Moreno, M.
    Guzman Martinez, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 297 - 297
  • [50] New techniques for imaging human immunodeficiency virus-associated cognitive impairment in the era of highly active Antiretroviral therapy
    Pomper, Martin G.
    Sacktor, Ned
    ARCHIVES OF NEUROLOGY, 2007, 64 (09) : 1233 - 1235